Doctors are working 24/7 to help those with a rare form of leukemia

There’s something to be said about round-the-clock care, and a dedicated staff of oncologists are providing just that to patients with a very rare cancer, acute promyelocytic leukemia (APL).

Dr. Anand Jillella, chief of the Division of Hematology/Oncology at the Medical College of Georgia at Augusta University, is one of the NCI-funded trial’s co-principal investigators, and he’s working to see if 24/7 care can help more patients survive the often complicated first few weeks of treatment.

Cancer Currents blog: Unique Trial Aims to Decrease Early Deaths in Patients with Rare Leukemia

Jan. 3, 2018

Like Love Haha Wow Sad Angry
Written by
Emily Lacey

Emily Lacey is a writer in the Division of Communications & Marketing at Augusta University. Contact her to schedule an interview on this topic or with one of our experts at 706-721-6144

View all articles
Written by Emily Lacey

Jagwire is your source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia.

Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences.